‘The 26 national laboratories can produce generic without a doubt,’ said Luis Caballero, president of the National Association of Pharmaceutical Industries. The new Medicines Act, which among other things, promotes the use of generic drugs has been well received. However, its implementation and enforcement are some clouds on the horizon.In this regard, a group of experts discussed at Saturday Focus RPP. The president of the National Association of Pharmaceutical Industries (ADIF), Luis Caballero, said the 26 national laboratories are in the ability to manufacture quality generic drugs. “I want to clarify that the total Peruvian imperfect market, 65 if not 70 per cent of production is generic, as the largest consumer unit level tablets and blisters is the state, serving 8 million policyholders and two or three million on the Ministry of Health, “he said. “There are 26 national pharmaceutical laboratories. I would say that the national laboratories can produce generic without a doubt. We can make all the innovative products that are now protected by patent.This law is perfect, as long as everyone put the shoulder, “he said. In this regard, an internist Manuel Vargas Giron said the country has a serious problem about drugs, since access to these is limited mainly due to an economic problem. “The wording of the legislation moves to solve the problem of access. One concern of doctors is that not only (the patients) have access to the recipe, but that they meet all the treatment,” he said. In turn, Ciro Magui a, dean-elect of the Medical College of Peru, asked not to be “Satanic” to branded drugs, considering that for an effective cure certain evils can not rely on “generics only”. “I believe in generic, and you should see the patient’s side. But I also put myself in the issue of not demonizing all. Use pretty generic but not brand name drugs satanic. Must be negotiated with the multinationals to give a low cost .Priority must be given the generic and brand look that lower their prices, “he said. Finally, Victor Dongo Zegarra, CEO of Medicines, Supplies and Drugs, Ministry of Health (Digemid), said his institution is the ability to inspect pharmacies and drugstores, in order to offer quality products. “Digemit is able to supervise. Always has done well. The problem was that the laws do not allow him to develop his work. For example, one day a pharmacy was closed and opened again the next day,” Vazquez said. “Now, before any medication is put into market, will go to the laboratories of the Ministry of Health to see if it is quality or not.